Market Overview:
The global female stress urinary incontinence treatment devices market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of female stress urinary incontinence, technological advancements in treatment devices, and rising awareness about available treatments. The global female stress urinary incontinence treatment devices market is segmented by type into non-surgical and surgical treatments. The non-surgical segment is further sub-segmented into pelvic floor muscle training (PFMT), pessaries, and vaginal cones. The surgical segment is further sub-segmented into tension free vaginal tape (TVT), transobturator tape (TOT), mini sling surgery, and retropubic suspension surgery. In terms of application, the global female stress urinary incontinence treatment devices market is divided into gynecology clinics, hospitals, ambulatory surgical centers (ASCs), and other applications such as home care settings and long term care facilities. Geographically, the global female stress urinary incontinence treatment devices market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Female stress urinary incontinence treatment devices are used to help women who leak urine when they laugh, sneeze, or exercise. There are many different types of female stress urinary incontinence treatment devices available. Some work by holding the urethra closed so that urine cannot escape. Others work by providing support to the bladder and urethra so that the muscles can better control urination. Female stress urinary incontinence treatment devices are important because they can help women regain control over their lives and improve their quality of life.
Non-surgical Treatment:
Non-surgical treatment is a growing market with many opportunities for new entrants. The key drivers of the global non-surgical treatment, it's usage and growth factor in female stress urinary incontinence (FUI) devices market are increasing awareness about the various treatments available for FUI, rising disposable income & standard of living, changing lifestyle & eating habits.
Surgical Treatment:
Surgical treatment and it's usage in Female Stress Urinary Incontinence (FSUI) devices market is expected to witness significant growth over the forecast period. The major factor that propels the growth of this market includes increasing incidences of stress urinary incontinence among women across the globe. According to a study conducted by American Academy of Family Physicians, approximately 10% - 15% women are affected with stress urinary incontinence (SUI).
Application Insights:
Based on application, the market is segmented into gynecology clinic, hospitals and ambulatory surgical centers. The gynecology clinics held the largest share of female stress urinary incontinence treatment devices market in 2017 due to a large number of gynaecological surgeries that are performed there. Moreover, increasing awareness about FSI among women as well as men is expected to boost demand for these devices in this segment over the forecast period.
The hospital segment is anticipated to witness significant growth over the forecast period owing to an increase in prevalence of chronic diseases such as cancer and diabetes which increases risk of UTI's occurrence. In addition, growing investments by governments across various regions towards development and introduction of new healthcare facilities with better infrastructure will boost demand for these treatments further driving growth during future years.
Regional Analysis:
North America dominated the global female stress urinary incontinence treatment devices market in 2017. This can be attributed to the presence of a well-developed healthcare infrastructure, high awareness levels coupled with relatively higher disposable income in this region as compared to other regions. Moreover, increasing prevalence of urogynecology conditions such as urge urinary symptoms associated with vaginal childbirth and increased use of adult diapers are some additional factors responsible for regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising geriatric population and awareness about these treatments among women especially in developing countries such as India and China. In addition, government initiatives for creating awareness about these treatments are also expected to drive regional demand during the forecast period.
Growth Factors:
- Increasing awareness about female stress urinary incontinence and its treatment options
- Growing number of women suffering from female stress urinary incontinence
- Rising demand for minimally invasive and non-invasive female stress urinary incontinence treatment devices
- Technological advancements in female stress urinary incontinence treatment devices market
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Female Stress Urinary Incontinence Treatment Devices Market Research Report
By Type
Non-surgical Treatment, Surgical Treatment
By Application
Gynecology Clinic, Hospitals, Ambulatory Surgical Centers
By Companies
Johnson & Johnson, Bard Medical, American Medical Solutions, Boston ScientificTeleflex, Karl Storz and Coloplast, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Female Stress Urinary Incontinence Treatment Devices Market Report Segments:
The global Female Stress Urinary Incontinence Treatment Devices market is segmented on the basis of:
Types
Non-surgical Treatment, Surgical Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gynecology Clinic, Hospitals, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Bard Medical
- American Medical Solutions
- Boston ScientificTeleflex
- Karl Storz and Coloplast
- Johnson & Johnson
Highlights of The Female Stress Urinary Incontinence Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-surgical Treatment
- Surgical Treatment
- By Application:
- Gynecology Clinic
- Hospitals
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Female Stress Urinary Incontinence Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Female stress urinary incontinence treatment devices are medical devices that help women with stress urinary incontinence. These devices can help to improve the quality of life for women who experience this type of incontinence.
Some of the major companies in the female stress urinary incontinence treatment devices market are Johnson & Johnson, Bard Medical, American Medical Solutions, Boston ScientificTeleflex, Karl Storz and Coloplast, Johnson & Johnson.
The female stress urinary incontinence treatment devices market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Female Stress Urinary Incontinence Treatment Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Female Stress Urinary Incontinence Treatment Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Female Stress Urinary Incontinence Treatment Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Female Stress Urinary Incontinence Treatment Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Female Stress Urinary Incontinence Treatment Devices Market Size & Forecast, 2020-2028
4.5.1 Female Stress Urinary Incontinence Treatment Devices Market Size and Y-o-Y Growth
4.5.2 Female Stress Urinary Incontinence Treatment Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Non-surgical Treatment
5.2.2 Surgical Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Gynecology Clinic
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Female Stress Urinary Incontinence Treatment Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Female Stress Urinary Incontinence Treatment Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Non-surgical Treatment
9.6.2 Surgical Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Gynecology Clinic
9.10.2 Hospitals
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Non-surgical Treatment
10.6.2 Surgical Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Gynecology Clinic
10.10.2 Hospitals
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Non-surgical Treatment
11.6.2 Surgical Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Gynecology Clinic
11.10.2 Hospitals
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Non-surgical Treatment
12.6.2 Surgical Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Gynecology Clinic
12.10.2 Hospitals
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Non-surgical Treatment
13.6.2 Surgical Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Gynecology Clinic
13.10.2 Hospitals
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Female Stress Urinary Incontinence Treatment Devices Market: Competitive Dashboard
14.2 Global Female Stress Urinary Incontinence Treatment Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Bard Medical
14.3.3 American Medical Solutions
14.3.4 Boston ScientificTeleflex
14.3.5 Karl Storz and Coloplast
14.3.6 Johnson & Johnson
